Fulgent Genetics Inc reports results for the quarter ended in March - Earnings Summary

Fulgent Genetics

04/05/2022 16:43

* Fulgent Genetics Inc  FLGT.OQ  reported quarterly adjusted
earnings of $5.08​​ per share for the quarter ended in March.
The mean expectation of two analysts for the quarter was
for earnings of $3.86 per share.
    * Revenue fell 10.9% to $320.27 million from a year ago; 
analysts
expected $270.85 million. 
    * Fulgent Genetics Inc's reported EPS for the quarter was
$4.93​.
    * The mean earnings estimate of analysts had risen by
about 54.8%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Fulgent Genetics Inc shares had fallen by 9.2% this
quarter and
lost 43.6% so far this year.
    * The company reported quarterly net income of $153.98
million.
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $98.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 4 at 03:43 p.m.  ​All
figures in US dollars unless otherwise stated